Advanced Alzheimer’s Disease Patients Show Safe, Significant, and Persistent Benefit in 6-Month Bryostatin Trial

BACKGROUND: In pre-clinical studies, Bryostatin, MW (molecular weight) 904, has demonstrated synaptogenic, anti-apoptotic, anti-amyloid, and anti-tau tangle efficacies. OBJECTIVE: To identify AD patients who show significant cognitive benefit versus placebo when treated in a trial with chronic Bryos...

Descripción completa

Detalles Bibliográficos
Autores principales: Alkon, Daniel L., Sun, Miao-Kun, Tuchman, Alan J., Thompson, Richard E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657679/
https://www.ncbi.nlm.nih.gov/pubmed/37742657
http://dx.doi.org/10.3233/JAD-230868

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657679/
https://www.ncbi.nlm.nih.gov/pubmed/37742657
http://dx.doi.org/10.3233/JAD-230868

Ejemplares similares